Ardelyx (ARDX) Return on Capital Employed Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -494.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -649.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 4,853.00 |
| 10 | Ardelyx | 1.48 Bn | 1.25 Bn | 89.66 Mn | 3,464.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,464.00 |
| Dec 31, 2025 | 5,254.00 |
| Sep 30, 2025 | 11,933.00 |
| Jun 30, 2025 | 14,946.00 |
| Mar 31, 2025 | 15,211.00 |
| Dec 31, 2024 | 13,487.00 |
| Sep 30, 2024 | 10,068.00 |
| Jun 30, 2024 | 6,018.00 |
| Mar 31, 2024 | 3,802.00 |
| Dec 31, 2023 | 2,686.00 |
| Sep 30, 2023 | 3,164.00 |
| Jun 30, 2023 | 1,071.00 |
| Mar 31, 2023 | -509.00 |
| Dec 31, 2022 | -813.00 |
| Sep 30, 2022 | -3,910.00 |
| Jun 30, 2022 | -8,604.00 |
| Mar 31, 2022 | -9,936.00 |
| Dec 31, 2021 | -9,219.00 |
| Sep 30, 2021 | -9,710.00 |
| Jun 30, 2021 | -5,172.00 |
| Mar 31, 2021 | -2,192.00 |
| Dec 31, 2020 | -379.00 |
| Sep 30, 2020 | 3,517.00 |
| Jun 30, 2020 | 2,822.00 |
| Mar 31, 2020 | 2,598.00 |
| Dec 31, 2019 | -26.00 |
| Sep 30, 2019 | -3,550.00 |
| Jun 30, 2019 | -1,808.00 |
| Mar 31, 2019 | -2,789.00 |
| Dec 31, 2018 | -2,677.00 |
| Sep 30, 2018 | -1,344.00 |
| Jun 30, 2018 | -3,087.00 |
| Mar 31, 2018 | -3,449.00 |
| Dec 31, 2017 | -4,743.00 |
| Sep 30, 2017 | -7,963.00 |